MedPath

Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With Gastroschisis

Phase 2
Terminated
Conditions
Gastroschisis
Registration Number
NCT00539292
Lead Sponsor
The Hospital for Sick Children
Brief Summary

This study seeks to evaluate whether the routine, primary use of the spring-loaded silo (SLS) to treat infants with gastroschisis will result in improved outcomes, faster recovery times and fewer post-surgical complications than the standard selective use of the silo.

Detailed Description

Standard treatment of the infant with gastroschisis consists of , the bowel being reduced into the abdomen, when possible,and the abdominal wall defect being closed in the operating room. When complete reduction of the eviscerated contents is not possible, a silastic " silo" is sewn on the abdominal wall and its contents are gradually reduced into the abdomen over several days. Once reduction is obtained, the silo is removed and the abdominal defect is closed.

Current methods of treatment are associated with significant morbidity, prolonged hospitalization, and high costs. Gastroschisis closure continues to be accompanied by a number of complications ranging from ileus, sepsis, TPN-related liver damage, necrotizing enterocolitis, respiratory insufficiency, and death. The optimal timing and method of closure, including primary versus secondary closure, continues to be debated. No prospective randomized studies to date have examined the routine use of the spring-loaded silo.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Diagnosis of Gastroschisis
  • Birth Weight ≥ 1500 grams
  • Gestational Age ≥ 34 weeks
Exclusion Criteria
  • Birth Weight < 1500 grams
  • Gestational Age < 34 weeks
  • Presence of Bowel Ischemia or Necrosis
  • Abdominal wall defect too small
  • Major associated anomalies or medical condition
  • Presence of Intracranial Hemorrhage (grade IV)
  • Parent Refusal for Randomization

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Ventilation StatusData collected daily during the first 14 days after the abdominal wall closure (measured in days)

length of time on the ventilator

Secondary Outcome Measures
NameTimeMethod
TPNData collected daily during the first 14 days after the abdominal wall closure, then monthly for 3 months until discharge (measured in days)

use of total parenteral nutrition (TPN)

Intraabdominal Pressure (IAP) as Reflected by Intragastric Pressureintraabdominal pressure at the time of definitive closure
Length of Hospital StayData collected daily during the first 14 days after the abdominal wall closure (measured in days), then monthly for 3 months until discharge.

days in hospital

Complications During Hospitalization (e.g., Sepsis)post-surgery to hospital discharge; Data collected daily during the first 14 days after the abdominal wall closure (measured in days), then monthly for 3 months until discharge.

Clinical sepsis confirmed with a positive blood culture

Trial Locations

Locations (1)

The Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

The Hospital for Sick Children
🇨🇦Toronto, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.